Bienaime Jean Jacques
Director
Disposition
Reported value range
Not reported
9,160 shares
Traded
Apr 14, 2026
Filed
Sep 28, 2026
You're reading the free version. Trader adds the live tape and alerts.
Start tracking
Ascendis Pharma A/S Ordinary Share
ASND
Transactions reported in official disclosures
Price with disclosed trades
Daily closes, past year · marks sit on transaction dates, sized by value
13 trades
| Reporting person | Filed | Transaction | Transaction value | Source | Actions |
|---|---|---|---|---|---|
| Bienaime Jean Jacques Director | Sep 28, 2026 167-day lag | Disposition Apr 14, 2026 | Not reported Reported range | SEC Form 4 View filing | |
| Bienaime Jean Jacques Director | Sep 28, 2026 167-day lag | Award Apr 14, 2026 | Not reported Reported range | SEC Form 4 View filing | |
| Bodenhoff Mads SVP & Pao | Sep 9, 2026 1-day lag | Exercise Sep 8, 2026 | $330K Filed shares x price | SEC Form 4 View filing | |
| Bodenhoff Mads SVP & Pao | Sep 9, 2026 1-day lag | Sale Sep 8, 2026 | $810.57K Filed shares x price | SEC Form 4 View filing | |
| Bodenhoff Mads SVP & Pao | Sep 9, 2026 1-day lag | Exercise Sep 8, 2026 | $0 Filed shares x price | SEC Form 4 View filing | |
| Holtug Lars Director | Sep 3, 2026 1-day lag | Sale Sep 2, 2026 | $62.33K Filed shares x price | SEC Form 4 View filing | |
| Bienaime Jean Jacques Director | Aug 18, 2026 4-day lag | Buy Aug 14, 2026 | $270.44K Filed shares x price | SEC Form 4 View filing | |
| Bienaime Jean Jacques Director | Aug 18, 2026 4-day lag | Buy Aug 14, 2026 | $222.22K Filed shares x price | SEC Form 4 View filing | |
| Smith Scott Thomas EVP & Chief Financial Officer | Jun 2, 2026 Same-day filing | Buy Jun 2, 2026 | $21.9K Filed shares x price | SEC Form 4 View filing | |
| Bienaime Jean Jacques Director | Jun 1, 2026 3-day lag | Buy May 29, 2026 | $44.75K Filed shares x price | SEC Form 4 View filing | |
| Bienaime Jean Jacques Director | Jun 1, 2026 3-day lag | Buy May 29, 2026 | $44.46K Filed shares x price | SEC Form 4 View filing | |
| Smith Scott Thomas EVP & Chief Financial Officer | Jun 1, 2026 3-day lag | Buy May 29, 2026 | $55.83K Filed shares x price | SEC Form 4 View filing | |
| Bienaime Jean Jacques Director | Jun 1, 2026 3-day lag | Buy May 29, 2026 | $22.35K Filed shares x price | SEC Form 4 View filing |
Bienaime Jean Jacques
Director
Award
Reported value range
Not reported
9,160 shares
Traded
Apr 14, 2026
Filed
Sep 28, 2026
Bodenhoff Mads
SVP & Pao
Exercise
Calculated transaction value
$330K
3,000 shares @ $110
Traded
Sep 8, 2026
Filed
Sep 9, 2026
Bodenhoff Mads
SVP & Pao
Sale
Calculated transaction value
$810.57K
3,000 shares @ $270.19
Traded
Sep 8, 2026
Filed
Sep 9, 2026
Bodenhoff Mads
SVP & Pao
Exercise
Calculated transaction value
$0
3,000 shares @ $0
Traded
Sep 8, 2026
Filed
Sep 9, 2026
Holtug Lars
Director
Sale
Calculated transaction value
$62.33K
236 shares @ $264.13
Traded
Sep 2, 2026
Filed
Sep 3, 2026
Bienaime Jean Jacques
Director
Buy
Calculated transaction value
$270.44K
1,100 shares @ $245.85
Traded
Aug 14, 2026
Filed
Aug 18, 2026
Bienaime Jean Jacques
Director
Buy
Calculated transaction value
$222.22K
900 shares @ $246.91
Traded
Aug 14, 2026
Filed
Aug 18, 2026
Smith Scott Thomas
EVP & Chief Financial Officer
Buy
Calculated transaction value
$21.9K
100 shares @ $219
Traded
Jun 2, 2026
Filed
Jun 2, 2026
Bienaime Jean Jacques
Director
Buy
Calculated transaction value
$44.75K
200 shares @ $223.76
Traded
May 29, 2026
Filed
Jun 1, 2026
Bienaime Jean Jacques
Director
Buy
Calculated transaction value
$44.46K
200 shares @ $222.3
Traded
May 29, 2026
Filed
Jun 1, 2026
Smith Scott Thomas
EVP & Chief Financial Officer
Buy
Calculated transaction value
$55.83K
250 shares @ $223.32
Traded
May 29, 2026
Filed
Jun 1, 2026
Bienaime Jean Jacques
Director
Buy
Calculated transaction value
$22.35K
100 shares @ $223.5
Traded
May 29, 2026
Filed
Jun 1, 2026